Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 3 12Phase 1 11Phase 1/2 5Phase NA 3Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia, Myeloid, Acute 11Neoplasm, Residual 3Leukemia 3Recurrence 2Leukemia, Promyelocytic, Acute 2Burkitt Lymphoma 2Myelodysplastic Syndromes 1Meningitis 1Meningeal Neoplasms 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 4Vincristine 2selinexor 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1apatinib 1VAP-cyclo protocol 1Thiotepa 1Rituximab 1Radiotherapy 1R-CHOP protocol 1Prednisone 1Nurse Clinicians 1Methotrexate 1Melphalan 1Lomustine 1Ifosfamide 1Idarubicin 1Filgrastim 1Etoposide 1Epirubicin 1Doxorubicin 1Dexamethasone 1Decitabine 1Cytarabine 1Carmustine 1Brentuximab Vedotin 1Blood Pressure 1Antiretroviral Therapy, Highly Active 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Large B-Cell, Diffuse × Cytarabine × Clear all
NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting
300 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡